Conference Coverage
Latest News
Autoimmune Skin Diseases Linked To Risk Of Adverse Pregnancy Outcomes
The three most common autoimmune skin diseases in the study cohort were vitiligo (30%), alopecia areata (30%), and cutaneous lupus erythematosus (...
Latest News
Dietary supplements may play a role in managing vitiligo
Overall, there is a “paucity of large, high-quality trials for [complementary] therapies for vitiligo,” said Ammar Ahmed, MD.
Conference Coverage
Low-dose aspirin provokes no flares in patients with IBD during pregnancy
Study provides more data on the safety of aspirin use during pregnancy in patients with IBD.
Latest News
Nail psoriasis in Black patients often overlooked
Clinical training might explain the delay in diagnosis of nail psoriasis in patients with darker skin types.
Latest News
At 52 weeks, complete hair regrowth rates still climbing on deuruxolitinib
Complete responses continued to increase in open-label extensions of phase 3 alopecia areata studies.
Latest News
Tapinarof effective for AD in patients as young as 2 years
Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.
Latest News
Hidradenitis suppurativa: Two anti-IL17A/F therapies yield positive results
Two biologics that inhibit both IL-17A and 17F effectively controlled hidradenitis suppurativa in phase 3 trials.
Guidelines
Conditional recommendations rule in new SARD-associated interstitial lung disease guidelines
“Clinicians must retain the latitude to prescribe medications based on individual patient factors and preferences.”
Conference Coverage
Abatacept reduced rates of progression to RA, phase 2b trial finds
The study was conducted at 28 sites in the United Kingdom and 3 in The Netherlands.
Conference Coverage
Risks quantified in medically optimized pregnancy with lupus
Patients who were not medically optimized for pregnancy were three times more likely to experience preterm birth and preeclampsia.
Conference Coverage
‘Smart’ stethoscope spots peripartum cardiomyopathy
Finding that 4% of the women in the intervention arm had reduced ejection fraction is “absolutely startling ... and speaks to how important...